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Abstract To investigate the function of the laminin K5-chain,
previously identified in mice, cDNA clones encoding the 953-
amino-acid carboxy terminal G-domain of the human laminin
K5-chain were characterized. Northern blot analysis showed that
the laminin K5-chain is expressed in human placenta, heart, lung,
skeletal muscle, kidney, and pancreas. The human laminin K5-
chain gene (LAMA5) was assigned to chromosome 20q13.2-
q13.3 by in situ hybridization, and the mouse gene (Lama5) was
mapped by linkage analysis to a syntonic region of distal
chromosome 2, close to the locus for the ragged (Ra) mutation.
z 1997 Federation of European Biochemical Societies.
Key words: Basement membrane; cDNA cloning;
Gene mapping; Laminin
1. Introduction
The laminins are the principal non-collagenous components
of basement membranes, and they also in£uence cell behavior
by interacting with a number of cell-surface receptors [1^4].
Each laminin molecule is a composed of three non-identical
subunits, called the K-, L-, and Q-chains. In mammals 10 dif-
ferent laminin chains have been identi¢ed, which can assemble
into laminin heterotrimers of diverse structure and function
[3,4]. The ¢ve known laminin K-chains have diverse N-termi-
nal structures, but they all possess an V100 kDa globular
domain, the G-domain, at their C-termini. The G-domain is
made up of ¢ve homologous repeats (G1^G5) ofV180 amino
acids and is part of the major cell-binding site located in the
long arm of the laminin heterotrimer. The biomedical impor-
tance of the laminin K-chains is emphasized by the discovery
of disease-causing mutations in the genes for at least two K-
chains: de¢ciencies in the K2-chain lead to muscular dystro-
phy in humans and mice [5^7], and mutations in the K3-chain
are found in some cases of the lethal blistering human skin
disorder Herlitz junctional epidermolysis bullosa [8].
The most recently described laminin K-chain, K5, was ini-
tially cloned in mice and found to be more homologous to a
Drosophila laminin K-chain than to the other four mammalian
K-chains [9]. Expression of the laminin K5-chain mRNA in
several developing and adult mouse tissues, including the
heart and kidney, suggests that it may be a major constituent
of basement membranes in these tissues [9,10]. Whether the
K5-chain is a subunit of biologically active laminin isoforms
isolated from human placenta [11] and bovine kidney [12]
remains to be determined. To aid in elucidating the function
of the laminin K5-chain, we have isolated cDNA clones en-
coding the G-domain of the human laminin K5-chain and
determined the tissue-speci¢c expression and chromosomal
localization of the human gene. Mapping of the mouse gene
to distal chromosome 2 by linkage analysis indicates that it
may be a possible candidate gene for the ragged (Ra) muta-
tion.
2. Materials and methods
2.1. Isolation and sequencing of cDNA clones
Potential human laminin K5-chain expressed sequence tags were
identi¢ed by searching the Human cDNA Database of The Institute
for Genome Research (available via the World Wide Web at URL
http://www.tigr.org) against the C-terminus of the translated mouse
laminin K5-chain cDNA sequence (GenBank U37501 [9]). The 0.6 kb
insert of one cDNA clone (IMAGE Consortium clone no. 155198/
GenBank R70310; obtained from the American Type Culture Collec-
tion) was used to screen a human placenta cDNA library in Vgt11
(Clontech H1008b) by plaque hybridization [13], resulting in the iso-
lation of a clone with a 1.6 kb insert, clone 1047. The remainder of the
G-domain cDNA was obtained by PCR ampli¢cation from a human
placenta cDNA library in pACT2 (Clontech HL4025AH), using Pfu
polymerase (Stratagene) and a sense primer corresponding to nt 7959^
7978 of the mouse cDNA sequence (5P-GGTGCCATGAAGTT-
CAATG) and an antisense primer derived from a sequence at the 5P
end of clone 1047 (5P-GTTGTAATGGTGCCAGACTC). The 1.6 kb
PCR product was cloned into the pCR-Script SK vector (Stratagene)
to give plasmid 1079. An additional cDNA clone with a 2.9 kb insert
(1140) was isolated by screening a human placenta 5P STRETCH
PLUS library in Vgt11 (Clontech HL5014b) with a restriction frag-
ment of 1079. The inserts of the cDNA clones in Vgt11 were subcl-
oned into pBluescript SK+ (Stratagene) for further analysis. The
cDNA was sequenced on both strands using Sequenase enzyme and
reagents (Amersham), and analysis of the sequence was carried out
using the software programs of the Wisconsin Package, Version 8.1,
of the Genetics Computer Group.
2.2. Northern blot hybridization
A human multiple tissue Northern blot, containingV2 Wg per lane
of poly A-enriched RNA from eight human tissues, was purchased
from Clontech (7760-1). Total RNA was extracted from cultured hu-
man cell lines using the Trizol reagent (Life Technologies), fraction-
ated by formaldehyde^agarose gel electrophoresis, and blotted onto
nylon membranes using standard protocols [13]. The insert of clone
1047 was labeled with [
32
P]dCTP by the random primer method using
a kit from Amersham. Hybridization was performed for 1 h at 68³C
in 10 ml per blot of QuikHyb solution (Stratagene), and the blots
were washed to a ¢nal stringency of 0.1USSC at 50³C and exposed
to Kodak X-Omat AR ¢lm at 370³C with intensifying screens.
2.3. Mapping of the human gene by in situ hybridization
Clone 1047 in pBluescript was labeled with tritium by nick-trans-
lation and used as a probe for in situ hybridization to chromosome
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spreads obtained from human lymphocytes. Preparation of chromo-
somes, hybridization, autoradiography, and chromosome banding
were performed as previously described [14,15]. For £uorescence in
situ hybridization, the same probe was labeled with biotin^16-dUTP
(Boehringer-Mannheim) and hybridized to metaphase spreads accord-
ing to the method of Pinkel et al. [16]. The hybridized probe was
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Fig. 1 (¢gure caption on page 298).
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detected by means of £uorescein isothiocyanate-conjugated avidin
(Vector Laboratories), and chromosomes were counterstained and
R-banded with propidium iodide as described in Lemieux et al. [17].
2.4. Linkage mapping of the mouse gene
To screen for informative DNA polymorphisms, we ampli¢ed and
sequenced a PCR product from both C57BL/6J and Mus spretus
(SPRET/Ei) genomic DNAs (obtained from The Jackson Laboratory
Mouse DNA Resource), using primers derived from the mouse cDNA
sequence. The C57BL/6J allele contained a StuI site (AGGCCT, lo-
cated in a 111-bp intron between nt 9267 and 9268 of the cDNA
sequence) that was absent in the M. spretus allele (AGGCTT). The
94 progeny of the Jackson Laboratory (C57BL/6JEiUSPRET/Ei)-
F1USPRET/Ei backcross panel (designated BSS) [18] were genotyped
for the polymorphic StuI site. Aliquots of genomic DNA (100 ng/50 Wl
reaction) were ampli¢ed with the primers 5P-dTTTGGCTTTCGTG-
GCACCCAGG (nt 9214^9235) and 5P-dATAGAAGGCAACA-
TAGTGAGGAGC (nt 9361^9384), using AmpliTaq DNA polymer-
ase and reagents (Perkin-Elmer). After an initial denaturation at 94³C
for 2 min, 35 cycles of 94³C for 40 s, 55³C for 40 s, and 72³C for 60 s
were run. The puri¢ed PCR products were digested with StuI and
separated on 5% polyacrylamide/0.5UTBE gels to score for presence
of the C57BL/6J allele, indicated by cleavage of the 282-bp PCR
product to yield bands of 98 and 184 bp. Analysis of the data and
chromosomal assignment of the mouse gene were performed by The
Jackson Laboratory Backcross Mapping Service.
3. Results and discussion
We have isolated and characterized overlapping cDNA
clones that encode the C-terminal G-domain of the human
laminin K5-chain. The composite sequence contains an open
reading frame of 2859-bp encoding 953 amino acids, followed
by a TAG stop codon and a 3P untranslated region of either
179 nt (clone 1047 and clone 155198) or 269 nt (clone 1140),
due to alternative use of an AATAAA polyadenylation signal
at nt 3016 or an ATTAAA polyadenylation signal at nt 3111
(Fig. 1A). The amino acid sequences of the human and mouse
laminin K5-chain G-domains have an overall identity of 72%,
with a greater similarity in the G1 and G2 repeats (s 80%
identity) than in the G4 and G5 repeats (61% identity) (Fig.
1B). An extra pair of cysteine residues (amino acids 430 and
920) are present in the human sequence, and the spacer region
between the G3 and G4 repeats is seven residues longer than
in the mouse sequence. When compared to the sequence of the
other four known laminin K-chains, the laminin K5 G-domain
has the greatest similarity to that of the K3-chain and the least
to that of the K2-chain (Fig. 1B). The degree of sequence
identity varies among the ¢ve G-repeats, suggesting that
they may perform di¡erent functions.
The distribution of laminin K5-chain mRNA in human tis-
sues was analyzed by hybridizing the
32
P-labeled insert of
clone 1047 to a multiple tissue Northern blot. A single laminin
K5-transcript ofV12 kb was detected in placenta and in adult
heart, lung, kidney, skeletal muscle, and pancreas, with little
or no expression in brain and liver (Fig. 2). The laminin K5
message was also observed on Northern blots of total RNA
extracted from several human cell lines, including clone A
colon carcinoma, A431 epidermoid carcinoma, and JAR cho-
riocarcinoma cells (not shown), suggesting that human cell
lines may prove useful for studying the synthesis and process-
ing of the K5-chain.
The chromosomal localization of the human laminin K5-
chain gene (LAMA5) was determined by in situ hybridization.
Upon examination of 100 metaphase cells hybridized to a
tritiated K5-chain cDNA probe, 183 silver grains were asso-
ciated with chromosomes; 46 silver grains were located on
human chromosome 20, with 41 of these (89%) non-randomly
distributed on the q13.2-q13.3 bands of the long arm, with the
maximum on the q13.3 band (Fig. 3A). When £uorescence in
situ hybridization was performed using a biotinylated probe,
90% of 50 metaphase cells examined showed speci¢c £uores-
cent signals on the 20q13.3 band (not shown). The mouse
gene (Lama5) was mapped by linkage analysis using an inter-
speci¢c backcross panel. Segregation of a polymorphic StuI
site in the backcross progeny revealed that Lama5 was linked
to markers on distal mouse chromosome 2 (Fig. 3B,C).
Lama5 was mapped 3.2þ 1.8 cM distal to Gnas, the gene
encoding the K-subunit of the stimulatory G-protein, and
1.1 þ 1.1 cM proximal to the microsatellite markers
D2Mit74, D2Mit266, and D2Mit457. LAMA5 and Lama5
are members of a large conserved linkage group that includes
all of human chromosome 20 and the distal region of mouse
chromosome 2 [19]. Based on the position of Lama5 relative
to other genes on mouse chromosome 2, LAMA5 is predicted
to reside distal to GNAS1 (the human homologue of Gnas)
and EDN3 (endothelin-3) on human chromosome 20.
The human laminin K5-chain gene does not appear to be a
likely candidate gene for any genetic disorders assigned so far
to the long arm of human chromosome 20 [20], but the mouse
gene maps very close to the locus of semidominant ragged
(Ra) mutation on distal chromosome 2 [21]. Ra heterozygotes
have sparse fur due to a de¢ciency of certain hair follicle
types, while Ra homozygotes lack fur, are frequently edema-
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Fig. 1. (A) Composite sequence of the human laminin K5-chain cDNA clones encoding the C-terminal G-domain. The nucleotide sequence is
on the top line, and the deduced amino acid sequence, in the one letter code, is on the bottom line. An asterisk indicates the TAG stop codon.
The two polyadenylation signals found in the cDNA clones are underlined, and the poly A addition site in clone 1047 is marked by an up ar-
row. Cysteine residues are circled. The boundaries between the subdomains of the G-domain (the G1^G5 repeats and the spacer region between
the G3 and G4 repeats) were assigned according to the criteria of Garrison et al. [27] and Richards et al.[28], and a right arrow is placed be-
neath the ¢rst residue of each domain. (B) Comparison of the human laminin K5-chain G-domain sequence to that of the mouse laminin K5-
chain (residues 2662^3610 of GenBank U37501 [9]) and to the G domains of the other four human K-chains: K1 (residues 3126^3075 of
SWISS-PROT P25391 [29]), K2 (residues 2154^3110 of GenBank Z26653 [30]), K3 (residues 777^1713 of GenBank L34155 [31]), and K4 (resi-
dues 835^1816 of GenBank X91171 [28]). The sequences were aligned and the percent identity calculated with the GAP program using the de-
fault parameters.
6
Fig. 2. Northern blot analysis of the tissue distribution of the hu-
man laminin K5-chain mRNA. The
32
P-labeled insert of clone 1047
was hybridized to a human multiple tissue Northern blot containing
2 Wg per lane of poly A+ RNA from heart (lane 1), brain (2), pla-
centa (lane 3), lung (lane 4), liver (lane 5), skeletal muscle (lane 6),
kidney (lane 7), and pancreas (lane 8). The signal in lane 2 may be
an artifact.
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tous, and display a high rate of pre- and perinatal lethality
due to unknown causes [22,23]. The laminin K5-chain is ex-
pressed in skin [9], consistent with a role in hair follicle devel-
opment, and it is also present in the heart and kidney [9,10],
two organs in which dysfunction can produce edema. The Ra
mutation occurs in the ROP (Ra/+ Os/+ Pt/+) mutant strain
of mice, which have nephrogenic defects resulting from the Os
(oligosyndactyly) mutation [24]. The ROP mice were found to
have enhanced levels of glomerulosclerosis and glomerular
laminin protein and laminin L1-chain mRNA accumulation
compared to Os/+ mice on a C57BL/6J genetic background
[25]. Loss of one laminin chain may lead to overexpression of
another, as was observed in the laminin L2-chain knock-out
mice [26]. Thus, the laminin K5-chain should be evaluated as a
potential candidate gene for the Ra mutation; alternatively, it
may serve as a marker for positional cloning of the Ra gene.
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Fig. 3. Chromosomal localization of the human and mouse laminin
K5-chain genes. (A) Idiogram of G-banded human chromosome 20,
showing the distribution of labeled sites observed when the tritium-
labeled human laminin K5-chain cDNA clone 1047 was hybridized
to chromosome preparations. (B): Linkage map of the distal region
of mouse chromosome 2, showing the position of Lama5 in relation
to £anking markers. (C) Haplotype analysis of the 94 Jackson Lab-
oratory BSS backcross progeny for Lama5 and selected £anking
markers. Columns represent the genotypes of the backcross progeny,
with white boxes indicating mice homozygous for the M. spretus al-
lele and black boxes indicating mice heterozygous for the C57BL/6J
and M. spretus alleles. The number of progeny with each haplotype
is given below the columns. To the right, the column labeled R lists
the distances between markers in cM, and the column marked SE
lists the standard errors for the map distances. Complete data for
Lama5 and other markers mapped on the Jackson Laboratory BSS
backcross panel are available electronically at World Wide Web
URL http://www.jax.org/resources/documents/cmdata.
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